Extragenital STDs mostly seen in throat and rectum, contribute to risk for drug-resistant gonorrhea and HIV
Psychiatrists can help adolescent and young adult patients with bipolar disorder address risky sexual behavior and can provide regular medication intervention to reduce the risk for STIs.
Rate of complete resolution of CIN2/3 significantly higher for HPV vaccine group versus placebo group.
Among tenofovir gel users, detection of plasma tenofovir may be associated with a reduced risk for herpes simplex virus type 2.
Transmission of human papillomavirus is unlikely to occur from hand-to-genital contact.
More research may be needed comparing antibiotic regimens to treat Chlamydia trachomatis in men and nonpregnant women.
High-risk human papillomavirus infection may be associated with the risk for cardiovascular disease in Korean women.
The majority of genital HPV infections are likely to be caused by genital-to-genital sexual transmission, not hand-to-genital contact.
Decline observed in HPV type 16/18 cervical precancers.
The prevalence of anogenital warts has decreased, with significant declines observed in specific populations.
Herpes zoster virus continues to be prevalent in certain patient demographics in the United States.
Valacyclovir was not efficacious in the study, perhaps because HSV-1 was in the dormant, nonactivated state and therefore non-responsive to valacyclovir effects.
The likelihood of a STI decreases for serially monogamous individuals when the time between partners is >4 months for women and >6 months for men.
Rapid testing for C trachomatis and N gonorrhoeae in the ED may lead to a significant reduction in overtreatment for women without infections.
The rate of syphilis has been increasing in peripartum women in the United States.
Initial treatment for C trachomatis in hospitalized women with PID showed significant improvements in rates of surgical intervention and mortality.
For treatment of HPV positive low-risk oropharyngeal cancer, cetuximab shows no benefit compared with the standard cisplatin regimen in terms of reduced toxicity and results in worse tumor control.
The risk for herpes zoster (zoster) is elevated during the two years preceding diagnosis and during treatment of hematological cancer.
Zoliflodacin was effective in treating gonococcal urogenital and rectal infections, but less effective in the treatment of pharyngeal gonorrhea.
From 2012 to 2016, there was a 61 percent increase in syphilis cases among pregnant women, with no traditional behavioral risk factors reported among half of these women.